Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Sales | 64,608 | 24,090 | 23,570 | 26,614 | 34,195 |
| Gross Profit | 64,608 | 24,090 | 23,570 | 26,614 | 34,195 |
| Operating Expenses | 51,975 | 58,617 | 61,635 | 59,206 | 44,547 |
| Operating Income | 12,633 | -34,527 | -38,065 | -32,592 | -10,352 |
| Other Income | 1,126 | 1,339 | 1,157 | 833 | 51,891 |
| Pre-tax Income | 13,759 | -33,188 | -36,908 | -31,759 | 41,539 |
| Net Income Continuous | 13,759 | -33,188 | -36,908 | -31,759 | 41,539 |
| Net Income | $13,759 | $-33,188 | $-36,908 | $-31,759 | $41,539 |
| EPS Basic Total Ops | 0.20 | -0.44 | -0.50 | -0.46 | 0.61 |
| EPS Basic Continuous Ops | 0.20 | -0.44 | -0.50 | -0.46 | 0.61 |
| EPS Diluted Total Ops | 0.20 | -0.44 | -0.50 | -0.46 | 0.61 |
| EPS Diluted Continuous Ops | 0.20 | -0.44 | -0.50 | -0.46 | 0.61 |
| EBITDA(a) | $16,144 | $-32,428 | $-35,923 | $-31,001 | $-8,125 |